Dublin, April 22, 2025 (GLOBE NEWSWIRE) — The “Lipid-Based Pharma Excipients Market – Global Outlook & Forecast 2025-2030” report has been added to ResearchAndMarkets.com’s offering.
The Lipid-Based Pharma Excipients Market was valued at USD 953.01 million in 2024, and is projected to reach USD 1.32 billion by 2030, rising at a CAGR of 5.63%.
The global lipid-based pharmaceutical excipients market has witnessed considerable growth in recent years, driven by increasing demand for novel drug delivery systems and the growing need for high-quality excipients to improve drug formulation. Lipid-based excipients, such as solid lipid nanoparticles, liposomes, and lipid emulsions, play a crucial role in enhancing the bioavailability, stability, and targeted delivery of poorly soluble drugs. As the demand for such excipients continues to rise, the competition in the lipid-based pharma excipients market has intensified, with several global players striving to gain a larger market share by offering innovative solutions and establishing strategic partnerships.
Innovation is at the forefront of the competitive strategies of many players in the lipid-based excipients market. Companies in the lipid-based pharma excipients market are focusing on developing new lipid formulations, enhancing existing products, and exploring novel drug delivery systems. For example, advancements in lipid nanoparticles and liposomes for drug encapsulation are driving growth in the lipid-based pharma excipients market. Significant R&D investments are critical to staying ahead in the competitive landscape.
Players like BASF and Lonza are constantly upgrading their product offerings to cater to emerging market needs. Furthermore, collaboration with other pharmaceutical and biotechnology firms is another key strategy for growth. Companies in the lipid-based pharma excipients market often form partnerships with drug manufacturers to develop specialized formulations for specific therapeutic areas. Additionally, acquisitions play a vital role in strengthening product portfolios and expanding market reach. Evonik Industries, for example, has expanded its presence through strategic acquisitions in the biopharmaceutical and excipient sectors.
MARKET TRENDS & DRIVERS
The industry is shifting toward natural and biodegradable lipid excipients in response to the demand for sustainable pharmaceutical products. Consumers are increasingly favoring greener alternatives, influenced by similar trends in food and cosmetics. Regulatory pressures like the European Green Deal also encourage the adoption of biodegradable materials. Additionally, recent advancements in lipid nanoparticles are enhancing drug delivery systems, increasing demand for high-quality lipid-based excipients integral to various formulations.
Advancements in lipid processing technologies, such as spray drying and melt extrusion, have revolutionized the production of lipid-based excipients, addressing challenges like poor extendibility and low encapsulation efficiency.
The market also sees rising demand for oral and topical formulations due to their ease of administration and non-invasive nature. These factors collectively contribute to the expansion of the lipid-based pharma excipients market. Furthermore, the growth of biopharmaceuticals and mRNA-based therapies has led to increased demand for specialized drug delivery systems, with lipid excipients playing a crucial role due to their ability to enhance drug solubility and stability.
GEOGRAPHICAL ANALYSIS
The global lipid-based pharma excipients market is expanding rapidly, driven by the growing demand for lipid-based drug delivery systems, the increased adoption of lipid nanoparticles in vaccines, and advancements in drug solubility enhancement technologies. North America, particularly the U.S. and Canada, holds a dominant position in the lipid-based pharma excipients market. The region benefits from a well-established pharmaceutical industry, strong R&D capabilities, and a high level of regulatory compliance. Furthermore, the U.S. is home to major pharmaceutical giants, such as Pfizer, Merck, and Moderna, which extensively use lipid-based excipients in drug formulations, including lipid nanoparticles for mRNA vaccines.
Europe is another major player in the global lipid-based pharma excipients market, with key countries including Germany, Switzerland, Ireland, Belgium, Italy, and the UK. The region is known for its focus on high-quality and sustainably sourced lipid excipients as well as strong pharmaceutical manufacturing capabilities. Furthermore, APAC is experiencing the fastest growth in the lipid-based pharma excipients market, with key contributors including China, Japan, India, South Korea, and Australia. This growth is fueled by rising pharmaceutical manufacturing, increasing investments in drug delivery technologies, and cost-effective production.
Latin America is an emerging lipid-based pharma excipients market, with key countries including Brazil, Mexico, Argentina, and Colombia. The region is witnessing increased pharmaceutical production, particularly in generic drugs and contract manufacturing. The region is home to a rapidly expanding generic drug market, and lipid-based excipients play a crucial role in the formulation of generic and innovative drugs, especially those requiring improved bioavailability.
Furthermore, the Middle East & Africa region represents a nascent but growing lipid-based pharma excipients market. The key countries driving demand include Turkey, Saudi Arabia, the UAE, and South Africa. The market is supported by increasing investments in pharmaceutical production and healthcare infrastructure. Also, the region’s expanding population and improving healthcare systems are increasing the need for advanced drug formulations.
COMPETITIVE LANDSCAPE
Key Vendors
- ABF Ingredients – ABITEC
- BASF
- Croda International
- Gattefose
- IOI Oleo GMbH
- Merck KGaA
Other Prominent Vendors
- AAK
- Alsiano
- Biopharma PEG Scientific
- CD Formulation
- CLARIANT
- Colorcon
- CordenPharma
- CREMER OLEO
- Evonik
- Kao Corporation
- Lipoid
- NOF CORPORATION
- Pothe Hille & Co
- The East Africa Wax Company
- VAV Life Sciences (VAV)
- WAXOILS
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 432 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $953.01 Million |
| Forecasted Market Value (USD) by 2030 | $1320 Million |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
Market Opportunities & Trends
- Growing Significance of Co-Processed Excipients
- Expanding Use of Lipid Excipients in Combination Therapies
- Growing Development of Long-Acting Injectable (Lai) Depot Formulations
- Growing Emphasis on Development of Multifunctional Lipid-Excipients
- Shift Toward Natural and Biodegradable Lipid Excipients
- Advancements in Lipid Nanoparticles and Drug Delivery Systems
Market Growth Enablers
- Advancements in Lipid Processing Technologies
- Rising Consumer Demand for Oral and Topical Formulations
- Growth of Biopharmaceuticals and MRNA-based Therapies
- Favorable Government Initiatives
- Growth in Self-Emulsifying Drug Delivery System
- Growing Focus on Biologics Spurring Increased Investments in Biologic Excipients
Market Restraints
- Supply Chain & Raw Material Sourcing Issues
- Availability of Alternative Pharma Excipients
- Complex Manufacturing and Processing of Lipid Excipients
- Regulatory and Quality Concerns
For more information about this report visit https://www.researchandmarkets.com/r/mhfwjx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Lipid-Based Pharma Excipients Market
